Samsung Bioepis Showcases Denosumab Data

Firm Publishes Phase I And Phase III Results For SB16 Proposed Biosimilar To Prolia

 
• By David Wallace
  
Samsung Bioepis has revealed trial results for its denosumab biosimilar
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Biosimilars

More from Products